The medical complications associated with purging

International Journal of Eating Disorders

Volumn 49, Issue 3, 2016, Pages 249-259

  Forney, K Jean ^a   Buchman Schmitt, Jennifer M ^a   Keel, Pamela K ^a   Frank, Guido K W ^b  

^a FLORIDA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

diuretic; laxative; medical complications; purging; self induced vomiting

Indexed keywords

DIURETIC AGENT; LAXATIVE;

BEHAVIOR DISORDER; CARDIOVASCULAR DISEASE; COMPLICATION; DISEASE ASSOCIATION; DRUG ABUSE; ESOPHAGUS DISEASE; EVIDENCE BASED MEDICINE; GASTROINTESTINAL DISEASE; HUMAN; KIDNEY DISEASE; MEDICAL COMPLICATION; MORTALITY; MUSCULOSKELETAL DISEASE; ORAL BLEEDING; PAROTID GLAND DISEASE; PRIORITY JOURNAL; PURGING; QUALITATIVE RESEARCH; REVIEW; SKIN DISEASE; STOMACH DISEASE; TOOTH DISEASE; VOMITING; DRUG DEPENDENCE; EATING DISORDER; FEMALE; MALE; PSYCHOLOGY;

FEEDING AND EATING DISORDERS; FEMALE; HUMANS; MALE; SUBSTANCE-RELATED DISORDERS; VOMITING;

EID: 84961828445     PISSN: 02763478     EISSN: 1098108X     Source Type: Journal    
DOI: 10.1002/eat.22504     Document Type: Review

References (147)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Arlington, VA: American Psychiatric Association, 2013.
2. Hay PJ, Mond J, Buttner P, Darby A., Eating disorder behaviors are increasing: Findings from two sequential community surveys in South Australia. PloS One 2008; 3: e1541.
3. Keel PK, Heatherton TD, Dorer DJ, Joiner TE, Zalta AK., Point prevalence of bulimia nervosa in 1982, 1992, and 2002. Psychol Med 2006; 36: 119-127.
4. Luce KH, Crowther JH, Pole M., Eating Disorder Examination Questionnaire (EDE-Q): Norms for undergraduate women. Int J Eat Disord 2008; 41: 273-276.
5. Haedt AA, Edler C, Heatherton TF, Keel PK., Importance of multiple purging methods in the classification of eating disorder subtypes. Int J Eat Disord 2006; 39: 648-654.
6. Dalle Grave R, Calugi S, Marchesini G., Self-induced vomiting in eating disorders: Associated features and treatment outcome. Behav Res Ther 2009; 47: 680-684.
7. Tozzi F, Thornton LM, Mitchell J, Fichter MM, Klump KL, Lilenfeld LR, et al., Features associated with laxative abuse in individuals with eating disorders. Psychosom Med 2006; 68: 470-477.
8. Bryant-Waugh R, Turner H, East P, Gamble C, Mehta R., Misuse of laxatives among adult outpatients with eating disorders: Prevalence and profiles. Int J Eat Disord 2006; 39: 404-409.
9. Edler C, Haedt AA, Keel PK., The use of multiple purging methods as an indicator of eating disorder severity. Int J Eat Disord 2007; 40: 515-520.
10. Favaro A, Santonastaso P., Purging behaviors, suicide attempts, and psychiatric symptoms in 398 eating disordered subjects. Int J Eat Disord 1996; 20: 99-103.
11. Tobin DL, Johnson C, Dennis AB., Divergent forms of purging behavior in bulimia nervosa patients. Int J Eat Disord 1992; 11: 17-24.
12. Koch S, Quadflieg N, Fichter M., Purging disorder: A comparison to established eating disorders with purging behaviour. Eur Eat Disord Rev 2013; 21: 265-275.
13. Arcelus J, Mitchell AJ, Wales J, Nielsen S., Mortality rates in patients with anorexia nervosa and other eating disorders: A meta-analysis of 36 studies. Arch Gen Psychiatry 2011; 68: 724.
14. Forney KJ, Haedt-Matt AA, Keel PK., The role of loss of control eating in purging disorder. Int J Eat Disord 2014; 47: 244-251.
15. Russell G., Bulimia nervosa: An ominous variant of anorexia nervosa. Psychol Med 1979; 9: 429-448.
16. Williams JF, Friedman IM, Steiner H., Hand lesions characteristic of bulimia. Am J Dis Child 1986; 140: 28-29.
17. Hediger C, Rost B, Itin P., Cutaneous manifestations in anorexia nervosa. Schweiz Med Wochenschr 2000; 130: 565-575.
18. Schwartz BK, Clendenning WE., A cutaneous sign of bulimia. J Am Acad Dermatol 1985; 12: 725-726.
19. Glorio R, Allevato M, De Pablo A, Abbruzzese M, Carmona L, Savarin M, et al., Prevalence of cutaneous manifestations in 200 patients with eating disorders. Int J Dermatol 2000; 39: 348-353.
20. Weinstein HD, Halabis JA., Subconjunctival hemorrhage in bulimia. J Am Optom Assoc 1986; 57: 366-367.
21. Conviser JH, Fisher SD, Mitchell KB., Oral care behavior after purging in a sample of women with bulimia nervosa. J Am Dent Assoc 2014; 145: 352-354.
22. Uhlen M, Tveit AB, Stenhagen KR, Mulic A., Self-induced vomiting and dental erosion-A clinical study. BMC Oral Health 2014; 14: 92.
23. Willumsen T, Graugaard PK., Dental fear, regularity of dental attendance and subjective evaluation of dental erosion in women with eating disorders. Eur J Oral Sci 2005; 113: 297-302.
24. Johansson A, Norring C, Unell L, Johansson A., Eating disorders and oral health: A matched case-control study. Eur J Oral Sci 2012; 120: 61-68.
25. Otsu M, Hamura A, Ishikawa Y, Karibe H, Ichijyo T, Yoshinaga Y., Factors affecting the dental erosion severity of patients with eating disorders. Biopsychosoc Med 2014; 8: 250759-8 -25.
26. Robb N, Smith B, Geidrys-Leeper E., The distribution of erosion in the dentitions of patients with eating disorders. Br Dent J 1995; 178: 171-175.
27. Hermont AP, Oliveira PA, Martins CC, Paiva SM, Pordeus IA, Auad SM., Tooth erosion and eating disorders: A systematic review and meta-analysis. PloS One 2014; 9: e111123.
28. Milosevic A, Dawson L., Salivary factors in vomiting bulimics with and without pathological tooth wear. Caries Res 1996; 30: 361-366.
29. Dynesen AW, Bardow A, Petersson B, Nielsen LR, Nauntofte B., Salivary changes and dental erosion in bulimia nervosa. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008; 106: 696-707.
30. Johansson A, Norring C, Unell L, Johansson A., Eating disorders and biochemical composition of saliva: A retrospective matched case-control study. Eur J Oral Sci 2015; 123: 158-164.
31. Fairburn CG., Cognitive Behavior Therapy and Eating Disorders. New York, NY: Guilford Press, 2008.
32. Davis R, Olmsted M, Rockert W, Marques T, Dolhanty J., Group psychoeducation for bulimia nervosa with and without additional psychotherapy process sessions. Int J Eat Disord 1997; 22: 25-34.
33. Vella-Zarb RA, Mills JS, Westra HA, Carter JC, Keating L., A randomized controlled trial of motivational interviewing self-help versus psychoeducation self-help for binge eating. Int J Eat Disord 2015; 48: 328-332.
34. Milosevic A., Tooth surface loss: Eating disorders and the dentist. Br Dent J 1999; 186: 109-113.
35. Aranha AC, Eduardo Cde P, Cordas TA., Eating disorders part II: Clinical strategies for dental treatment. J Contemp Dent Pract 2008; 9: 89-96.
36. Kisely S, Baghaie H, Lalloo R, Johnson NW., Association between poor oral health and eating disorders: Systematic review and meta-analysis. Br J Psychiatry 2015; 207: 299-305.
37. US Department of Health and Human Services. Oral Health in America: A Report of the Surgeon General. Rockville: National Institute of Dental and Craniofacial Research, National Institutes of Health, 2000.
38. Park KK, Tung RC, de Luzuiaga A., Painful parotid hypertrophy with bulimia: a report of medical management. J Drugs Dermatol 2009; 8: 577-579.
39. Bernard JD, Shearn MA., Psychogenic pseudo-Sjogren's syndrome. West J Med 1974; 120: 247-248.
40. Levin PA, Falko JM, Dixon K, Gallup EM, Saunders W., Benign parotid enlargement in bulimia. Ann Intern Med 1980; 93: 827-829.
41. Mandel L, Abai S., Diagnosing bulimia nervosa with parotid gland swelling. J Am Dent Assoc 2004; 135: 613-616.
42. Kinzl J, Biebl W, Herold M., Significance of vomiting for hyperamylasemia and sialadenosis in patients with eating disorders. Int J Eat Disord 1993; 13: 117-124.
43. Wolfe BE, Jimerson DC, Smith A, Keel PK., Serum amylase in bulimia nervosa and purging disorder: Differentiating the association with binge eating versus purging behavior. Physiol Behav 2011; 104: 684-686.
44. Mignogna M, Fedele S, Lo Russo L., Anorexia/bulimia-related sialadenosis of palatal minor salivary glands. J Oral Pathol Med 2004; 33: 441-442.
45. Rauch SD, Herzog DB., Parotidectomy for bulimia: A dissenting view. Am J Otolaryngol 1987; 8: 376-380.
46. Osborne RF, Hamilton JS., Parotidectomy for treatment of bulimic parotid hypertrophy. Ear Nose Throat J 2012; 91: 62.
47. Mehler PS, Wallace JA., Sialadenosis in bulimia: A new treatment. Archi Otolaryngol Head Neck Surg 1993; 119: 787-788.
48. Rothstein SG, Rothstein JM., Bulimia: The otolaryngology head and neck perspective. Ear Nose Throat J 1992; 71: 78-80.
49. Schöning H, Emshoff R, Kreczy A., Necrotizing sialometaplasia in two patients with bulimia and chronic vomiting. Int J Oral Maxillofac Surg 1998; 27: 463-465.
50. Imai T, Michizawa M., Necrotizing sialometaplasia in a patient with an eating disorder: Palatal ulcer accompanied by dental erosion due to binge-purging. J Oral Maxillofac Surg 2013; 71: 879-885.
51. Bannister M., Tonsillitis caused by vomiting in a patient with bulimia nervosa: A case report and literature review. Case Rep Otolaryngol 2013; 2013: 251629.
52. White JK, Carver J., Self-induced vomiting as a probable mechanism of an isolated hyoid bone fracture. Am J Forensic Med Pathol 2012; 33: 170-172.
53. Alcalay J, Ingber A, Sandbank M., Mask phenomenon: Postemesis facial purpura. Cutis 1986; 38: 28.
54. Kiss A, Wiesnagrotzki S, Abatzi T, Meryn S, Haubenstock A, Base W., Upper gastrointestinal endoscopy findings in patients with long-standing bulimia nervosa. Gastrointest Endosc 1989; 35: 516-518.
55. Rothstein SG., Reflux and vocal disorders in singers with bulimia. J Voice 1998; 12: 89-90.
56. Sansone RA, Sansone LA., Hoarseness: A sign of self-induced vomiting? Innov Clin Neurosci 2012; 9: 37.
57. Kiss A, Bergmann H, Abatzi TA, Schneider C, Wiesnagrotzki S, Hobart J, et al., Oesophageal and gastric motor activity in patients with bulimia nervosa. Gut 1990; 31: 259-265.
58. Nickl NJ, Brazer SR, Rockwell K, Smith JW., Patterns of esophageal motility in patients with stable bulimia. Am J Gastroenterol 1996; 91: 2544-2547.
59. Koch KL., Unexplained nausea and vomiting. Curr Treat Options Gastroenterol 2000; 3: 303-313.
60. Cellucci MF., Oral rehydration. Merck Manuals Professional Ed 2014. Available at: http://www.merckmanuals.com/professional/pediatrics/dehydration-and-fluid-therapy-in-children/oral-rehydration.
61. Wang WH, Huang JQ, Zheng GF, Xia HH, Wong WM, Liu XG, et al., Effects of proton-pump inhibitors on functional dyspepsia: A meta-analysis of randomized placebo-controlled trials. Clin Gastroenterol Hepatol 2007; 5: 178-185.
62. Moayyedi P, Delaney BC, Vakil N, Forman D, Talley NJ., The efficacy of proton pump inhibitors in nonulcer dyspepsia: A systematic review and economic analysis. Gastroenterology 2004; 127: 1329-1337.
63. Niklasson A, Lindström L, Simrén M, Lindberg G, Björnsson E., Dyspeptic symptom development after discontinuation of a proton pump inhibitor: A double-blind placebo-controlled trial. Am J Gastroenterol 2010; 105: 1531-1537.
64. Spechler SJ, Souza RF., Barrett's Esophagus. N Engl J Med 2014; 371: 836-845.
65. Dessureault S, Coppola D, Weitzner M, Powers P, Karl RC., Barrett's esophagus and squamous cell carcinoma in a patient with psychogenic vomiting. Int J Gastrointest Cancer 2002; 32: 57-61.
66. Matsha T, Stepien A, Blanco-Blanco E, Brink L, Lombard C, Van Rensburg S, et al., Self-induced vomiting-risk for oesophageal cancer? S Afr Med J 2006; 96: 209-212.
67. Brewster DH, Nowell SL, Clark DN., Risk of oesophageal cancer among patients previously hospitalised with eating disorder. Cancer Epidemiol 2015; 39: 313-320.
68. Malik M, Stratton J, Sweeney W., Rectal prolapse associated with bulimia nervosa: Report of seven cases. Female Pelvic Med Reconstruct Surg 1998; 4: 146.
69. Al Qarni MA, Jawaid S., Rupture of posterior gastric artery after vomiting: A rare cause of acute abdomen. Int J Surg Case Rep 2014; 5: 47-48.
70. Hayes N, Waterworth PD, Griffin SM., Avulsion of short gastric arteries caused by vomiting. Gut 1994; 35: 1137-1138.
71. Gowen GF, Stoldt HS, Rosato FE., Five risk factors identify patients with gastroesophageal intussusception. Arch Surg 1999; 134: 1394-1397.
72. Kirkcaldy RD, Kim TJ, Carney CP., A somatoform variant of obsessive-compulsive disorder: A case report of OCD presenting with persistent vomiting. Prim Care Companion J Clin Psychiatry 2004; 6: 195-198.
73. DeJong H, Perkins S, Grover M, Schmidt U., The prevalence of irritable bowel syndrome in outpatients with bulimia nervosa. Int J Eat Disord 2011; 44: 661-664.
74. Wang X, Luscombe GM, Boyd C, Kellow J, Abraham S., Functional gastrointestinal disorders in eating disorder patients: Altered distribution and predictors using ROME III compared to ROME II criteria. World J Gastroenterol 2014; 20: 16293.
75. Gupta R, Clarke DE, Wyer P., Stress fracture of the hyoid bone caused by induced vomiting. Ann Emerg Med 1995; 26: 518-521.
76. Siddiq MA, Selvadurai D, Narula AA., Subcutaneous cervical emphysema after self-induced vomiting. J R Soc Med 1999; 92: 192-193.
77. Sastry A, Karkos P, Leong S, Hampal S., Bulimia and oesophageal foreign bodies. J Laryngol Otol 2008; 122: e16.
78. Delap TG, Grant WE, Dick R, Quiney RE., Retropharyngeal abscess: An unusual complication of anorexia nervosa. J Laryngol Otol 1996; 110: 483-484.
79. Jones TM, Luke LC., Life threatening airway obstruction: A hazard of concealed eating disorders. J Accid Emerg Med 1998; 15: 332-333.
80. Riddlesberger JM, Cohen H, Glick P., The swallowed toothbrush: A radiographic clue of bulimia. Pediatr Radiol 1991; 21: 262-264.
81. Wilcox DT, Karamanoukian HL, Glick PL., Toothbrush ingestion by bulimics may require laparotomy. J Pediatr Surg 1994; 29: 1596.
82. Bennett HS, Spiro AJ, Pollack MA, Zucker P., Ipecac-induced myopathy simulating dermatomyositis. Neurology 1982; 32: 91-94.
83. Dresser LP, Massey EW, Johnson EE, Bossen E., Ipecac myopathy and cardiomyopathy. J Neurol Neurosurg Psychiatry 1993; 56: 560-562.
84. Ho PC, Dweik R, Cohen MC., Rapidly reversible cardiomyopathy associated with chronic ipecac ingestion. Clin Cardiol 1998; 21: 780-784.
85. Friedman AG, Seime RJ, Roberts T, Fremouw WJ., Ipecac abuse: A serious complication in bulimia. Gen Hosp Psychiatry 1987; 9: 225-228.
86. Schiff RJ, Wurzel CL, Brunson SC, Kasloff I, Nussbaum MP, Frank SD., Death due to chronic syrup of ipecac use in a patient with bulimia. Pediatr 1986; 78: 412-416.
87. Buchanan R, Ngwira J, Amsha K., Prolonged QT interval in bulimia nervosa. BMJ Case Rep 2011; 2011: 10.1136/bcr.01.2011.3780 [Epub ahead of print].
88. Genuardi FJ, Sturdevant MS., Generalized weakness. Adolesc Med 1996; 7: 357-359.
89. Adler AG, Walinsky P, Krall RA, Cho SY., Death resulting from ipecac syrup poisoning. JAMA 1980; 243: 1927-1928.
90. Joo JS, Ehrenpreis ED, Gonzalez L, Kaye M, Breno S, Wexner SD, et al., Alterations in colonic anatomy induced by chronic stimulant laxatives: The cathartic colon revisited. J Clin Gastroenterol 1998; 26: 283-286.
91. Muller-Lissner S., What has happened to the cathartic colon? Gut 1996; 39: 486-488.
92. Müller-Lissner SA, Kamm MA, Scarpignato C, Wald A., Myths and misconceptions about chronic constipation. Am J Gastroenterol 2005; 100: 232-242.
93. Duncan A, Forrest JA., Surreptitious abuse of magnesium laxatives as a cause of chronic diarrhoea. Eur J Gastroenterol Hepatol 2001; 13: 599-601.
94. Takakura S, Nozaki T, Nomura Y, Koreeda C, Urabe H, Kawai K, et al., Factors related to renal dysfunction in patients with anorexia nervosa. Eat Weight Disord 2006; 11: 73-77.
95. Wainscoat JS, Finn R., Possible role of laxatives in analgesic nephropathy. Br Med J 1974; 4: 697-698.
96. Park CW, You HY, Kim YK, Chang YS, Shin YS, Hong CK, et al., Chronic tubulointerstitial nephritis and distal renal tubular acidosis in a patient with frusemide abuse. Nephrol Dial Transplant 2001; 16: 867-869.
97. Mizuiri S, Ozawa T, Hirata K, Takezawa K, Kawamura S., Characteristic changes of the juxtaglomerular cells before and after treatment of pseudo-Bartter's syndrome due to furosemide abuse. Nephron 1987; 46: 23-27.
98. Wada K, Shinoda T., A case report of an anorexia nervosa patient with end-stage renal disease due to pseudo Bartter's syndrome and Chinese herb nephropathy requiring maintenance hemodialysis. Ther Apher Dial 2008; 12: 417-420.
99. Korzets Z, Hasdan G, Podjarny E, Bernheim J., Excessive fluid gain in a chronic laxative abuser: "Pseudo-idiopathic" oedema. Nephrol Dial Transplant 2002; 17: 161-162.
100. Lassen CK, Jespersen B., Management of diuretic treatment: A challenge in the obese patient. Scand J Urol Nephrol 2011; 45: 220-222.
101. Menahem SA, Perry GJ, Dowling J, Thomson NM., Hypokalaemia-induced acute renal failure. Nephrol Dial Transplant 1999; 14: 2216-2218.
102. Wright LF, DuVal JWJ., Renal injury associated with laxative abuse. South Med J 1987; 80: 1304-1306.
103. Kim YG, Kim B, Kim MK, Chung SJ, Han HJ, Ryu JA, et al., Medullary nephrocalcinosis associated with long-term furosemide abuse in adults. Nephrol Dial Transplant 2001; 16: 2303-2309.
104. Dick W, Lingeman J, Preminger G, Smith L, Wilson D, Shirrell W,. Laxative abuse as a cause for ammonium-urate renal calculi., Walker VR, Sutton RAL, Cameron ECB, Eds. New York, US: Springer; 1989. p. 303-305.
105. Leaf DE, Bukberg PR, Goldfarb DS., Laxative abuse, eating disorders, and kidney stones: A case report and review of the literature. Am J Kidney Dis 2012; 60: 295-298.
106. Bouquegneau A, Dubois BE, Krzesinski J, Delanaye P., Anorexia nervosa and the kidney. Am J Kidney Dis 2012; 60: 299-307.
107. Abraham S, Kellow JE., Do the digestive tract symptoms in eating disorder patients represent functional gastrointestinal disorders? BMC Gastroenterol 2013; 13: 38 230X-13-38.
108. Boyd C, Abraham S, Kellow J., Appearance and disappearance of functional gastrointestinal disorders in patients with eating disorders. Neurogastroenterol Motil 2010; 22: 1279-1283.
109. Siegers CP, von Hertzberg-Lottin E, Otte M, Schneider B., Anthranoid laxative abuse: A risk for colorectal cancer? Gut 1993; 34: 1099-1101.
110. Watanabe T, Nakaya N, Kurashima K, Kuriyama S, Tsubono Y, Tsuji I., Constipation, laxative use and risk of colorectal cancer: The Miyagi cohort study. Eur J Cancer 2004; 40: 2109-2115.
111. Citronberg J, Kantor ED, Potter JD, White E., A prospective study of the effect of bowel movement frequency, constipation, and laxative use on colorectal cancer risk. Am J Gastroenterol 2014; 109: 1640-1649.
112. Zhang X, Wu K, Cho E, Ma J, Chan AT, Gao X, et al., Prospective cohort studies of bowel movement frequency and laxative use and colorectal cancer incidence in US women and men. Cancer Cause Control 2013; 24: 1015-1024.
113. Dukas L, Willett WC, Colditz GA, Fuchs CS, Rosner B, Giovannucci EL., Prospective study of bowel movement, laxative use, and risk of colorectal cancer among women. Am J Epidemiol 2000; 151: 958-964.
114. Finsterer J, Stöllberger C., Recurrent aborted sudden cardiac death with seizures and rhabdomyolysis due to bulimia-induced hypokalemia. Rev Méd Chile 2014; 142.
115. Krahn LE, Lee J, Richardson J, Martin M, O'Connor M., Hypokalemia leading to torsades de pointes: Munchausen's disorder or bulimia nervosa? Gen Hosp Psychiatry 1997; 19: 370-377.
116. Riley JA, Brown AR, Walker BE., Congestive cardiac failure following laxative withdrawal. Postgrad Med J 1996; 72: 491-492.
117. Strivens E, Siddiqi A, Fluck R, Hutton A, Bell D., Hyperkalaemic cardiac arrest. May occur secondary to misuse of diuretics and potassium supplements. BMJ 1996; 313: 693.
118. Cawley DT, Curtin PT, McCabe JP., Hypokalaemic paralysis secondary to thiazide diuretic abuse: An unexpected outcome for cauda equina syndrome. Evid Based Spine Care J 2011; 2: 51.
119. Frame B, Guiang HL, Frost HM, Reynolds WA., Osteomalacia induced by laxative (phenolphthalein) ingestion. Arch Intern Med 1971; 128: 794-796.
120. Gwee KA, Kang JY., Surreptitious laxative abuse-An unusual cause of chronic diarrhoea. Singapore Med J 1990; 31: 596-598.
121. Cummings JH, Sladen GE, James OF, Sarner M, Misiewicz JJ., Laxative-induced diarrhoea: A continuing clinical problem. Br Med J 1974; 1: 537-541.
122. Krejs G, Walsh J, Morawski S, Fordtran J., Intractable diarrhea. Am J Dig Dis 1977; 22: 280-292.
123. LaRusso NF, McGill DB., Surreptitious laxative ingestion. Delayed recognition of a serious condition: A case report. Mayo Clin Proc 1975; 50: 706-708.
124. Slugg PH, Carey WD., Clinical features and follow-up of surreptitious laxative users. Cleve Clin Q 1984; 51: 167-171.
125. Harper J, Leung M, Birmingham C., A blinded laxative taper for patients with eating disorders. Eat Weight Disord 2004; 9: 147-150.
126. Weiss BD, Wood GA., Laxative abuse causing gastrointestinal bleeding. J Fam Pract 1982; 15: 177-181.
127. FitzGerald O, Redmond J., Anthraquinone-induced clubbing associated with laxative abuse. Ir J Med Sci 1983; 152: 246-247.
128. Riemann JF, Schenk J, Ehler R, Schmidt H, Koch H., Ultrastructural changes of colonic mucosa in patients with chronic laxative misuse. Acta Hepatogastroenterol (Stuttg) 1978; 25: 213-218.
129. Mitty RD, Wolfe GR, Cosman M., Initial description of gastric melanosis in a laxative-abusing patient. Am J Gastroenterol 1997; 92: 707-708.
130. Lesna M, Hamlyn AN, Venables CW, Record CO., Chronic laxative abuse associated with pancreatic islet cell hyperplasia. Gut 1977; 18: 1032-1035.
131. Brown NW, Treasure JL, Campbell IC., Evidence for long-term pancreatic damage caused by laxative abuse in subjects recovered from anorexia nervosa. Int J Eat Disord 2001; 29: 236-238.
132. Pines A, Olchovsky D, Bregman J, Kaplinsky N, Frankl O., Finger clubbing associated with laxative abuse. South Med J 1983; 76: 1071-1072.
133. Levine D, Goode A, Wingate D., Purgative abuse associated with reversible cachexia, hypogammaglobulinaemia, and finger clubbing. Lancet 1981; 317: 919-920.
134. Malmquist J, Ericsson B, Hulten-Nosslin MB, Jeppsson JO, Ljungberg O., Finger clubbing and aspartylglucosamine excretion in a laxative-abusing patient. Postgrad Med J 1980; 56: 862-864.
135. Vanderperren B, Rizzo M, Angenot L, Haufroid V, Jadoul M, Hantson P., Acute liver failure with renal impairment related to the abuse of senna anthraquinone glycosides. Ann Pharmacother 2005; 39: 1353-1357.
136. Wark H, Wallace E, Wigg S, Tippett C., Thyroxine abuse: An unusual case of thyrotoxicosis in pregnancy. Aust N Z J Obstet Gynaecol 1998; 38: 221-223.
137. Steel JM, Young RJ, Lloyd GG, Clarke BF., Clinically apparent eating disorders in young diabetic women: Associations with painful neuropathy and other complications. Br Med J (Clin Res Ed) 1987; 294: 859-862.
138. Custal N, Arcelus J, Aguera Z, Bove FI, Wales J, Granero R, et al., Treatment outcome of patients with comorbid type 1 diabetes and eating disorders. BMC Psychiatry 2014; 14: 140 244X-14-140.
139. Borus JS, Laffel L., Adherence challenges in the management of type 1 diabetes in adolescents: Prevention and intervention. Curr Opin Pediatr 2010; 22: 405-411.
140. Button EJ, Chadalavada B, Palmer RL., Mortality and predictors of death in a cohort of patients presenting to an eating disorders service. Int J Eat Disord 2010; 43: 387-392.
141. Crow S, Praus B, Thuras P., Mortality from eating disorders: A 5-to 10-year record linkage study. Int J Eat Disord 1999; 26: 97-101.
142. Brown CA, Mehler PS., Medical complications of self-Induced vomiting. Eating Disord 2013; 21: 287-294.
143. Silber TJ., Ipecac syrup abuse, morbidity, and mortality: Isn't it time to repeal its over-the-counter status? J Adolesc Health 2005; 37: 256-260.
144. Keel PK, Dorer DJ, Eddy KT, Franko D, Charatan DL, Herzog DB., Predictors of mortality in eating disorders. Arch Gen Psychiatry 2003; 60: 179-183.
145. Abebe DS, Lien L, von Soest T., The development of bulimic symptoms from adolescence to young adulthood in females and males: A population-based longitudinal cohort study. Int J Eat Disord 2012; 45: 737-745.
146. Pearson CM, Combs JL, Zapolski TCB, Smith GT., A longitudinal transactional risk model for early eating disorder onset. J Abnorm Psychol 2012; 121: 707-718.
147. Koch S, Quadflieg N, Fichter M., Purging disorder: A pathway to death? A review of 11 cases. Eat Weight Disord 2014; 19: 21-29.